Name Geoffrey Rose Education University of London | Role Ophthalmologist | |
Geoffrey Rose BSc MBBS MS DSc MRCP FRCS FRCOphth (born January 17, 1955) is an English Ophthalmologist and President of the British OculoPlastic Surgery Society (BOPSS).
Contents
Early life
Dr. Rose was born in 1955 in Purley (south London), England, son of Horace Edgar Rose, professor of engineering at King's College London. He was awarded a Bachelor of Science in Pharmacology, with first-class honours, in 1976. He attended the King's College Hospital Medical School, University of London, finishing in 1979. With further training in Internal Medicine, he was awarded Membership of the Royal College of Physicians in 1982. Dr. Rose received further training in ophthalmology at King's College Hospital, St Thomas Hospital and Moorfields Eye Hospital, with award of Fellowship of the Royal College of Surgeons and the Royal College of Ophthalmologists. He has a Master of Surgery (1990) for work on corneal endothelial changes after cataract surgery and a Doctor of Science (in Ophthalmology and Ophthalmic Surgery, 2004). His qualifications include BSc MBBS MS DSc MRCP FRCS FRCOphth.
Dr. Rose is a Consultant Orbital, Lacrimal and Plastic Reconstructive Surgeon and Director of the Adnexal Service at Moorfields Eye Hospital and has published over one hundred papers and articles on adnexal disease.
He is currently the president of the British OculoPlastic Surgery Society (BOPSS), and a member of the European Society of Ophthalmic Plastic and Reconstructive Surgeons, The Orbit Society and an honorary member of the American Society of Ophthalmic Plastic and Reconstructive Surgeons. He is a frequent speaker at seminars and meetings around the globe and he has delivered many prestigious lectures.
Research interests
Although primarily a clinician, Dr. Rose has carried out research into eye disease, a lifetime achievement which was recognised in 2001 when he was awarded a Doctor of Science degree, from the University of London . His most recent areas of research have included treatment of orbital amyloidosis, lacrimal drainage surgery, treatment of capillary hemangioma, monitoring of optic nerve glioma and ocular disease in lichen planus